Related Experiment Videos
Modern treatment strategies for patients with epilepsy: a review
1Institute of Neurology, National Hospital for Neurology and Neurosurgery, London.
Abstract:
Of patients who develop epilepsy 70-80% will become seizure free, the remaining 20% are the most difficult to treat satisfactorily. Eighty per cent of patients are best treated with a single drug. Stepwise treatment plans for the treatment of newly diagnosed patients and for the evaluation of patients with chronic epilepsy are suggested. There is a lack of consensus regarding the rate at which to taper antiepileptic drugs being discontinued in patients with active epilepsy. There are arguments for making drug changes rapidly; these arguments and strategies for managing the withdrawal of individual drugs are presented.
Insights
Most epilepsy patients achieve seizure freedom with treatment. This study addresses challenges in managing the remaining 20% with refractory epilepsy and discusses antiepileptic drug tapering strategies.
Area of Science:
- Neurology
- Clinical Pharmacology
Background:
- Epilepsy affects a significant portion of the population, with 70-80% achieving seizure control.
- A challenging 20% of patients present with refractory epilepsy, requiring optimized treatment strategies.
- Current treatment paradigms favor monotherapy for the majority of epilepsy cases.
Purpose of the Study:
- To outline stepwise treatment plans for newly diagnosed and chronic epilepsy patients.
- To address the lack of consensus on the rate of antiepileptic drug (AED) discontinuation.
- To present arguments and strategies for rapid drug changes and withdrawal management in epilepsy.
Main Methods:
- Review of existing treatment guidelines and clinical practices for epilepsy management.
- Analysis of strategies for stepwise treatment initiation and evaluation.
- Discussion of evidence and rationale for rapid versus gradual AED tapering.
Main Results:
- Stepwise treatment approaches are proposed for both new and chronic epilepsy diagnoses.
- Monotherapy is effective for approximately 80% of epilepsy patients.
- Arguments for rapid AED discontinuation and withdrawal management are presented, highlighting a need for consensus.
Conclusions:
- Effective management strategies are crucial for the 20% of epilepsy patients with refractory seizures.
- Standardized protocols for AED tapering are needed to optimize patient care.
- Further research and consensus are required for managing drug withdrawal in active epilepsy.